Neuroblastoma as an experimental model for neuronal differentiation and hypoxia-induced tumor cell dedifferentiation

Brodeur, 1993, Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment, J Clin Oncol, 11, 1466, 10.1200/JCO.1993.11.8.1466

Hedborg, 1995, Biochemical evidence for a mature phenotype in morphologically poorly differentiated neuroblastomas with a favorable outcome, Eur J Cancer, 4, 435, 10.1016/0959-8049(95)00025-E

Patterson, 1990, Control of cell fate in a vertebrate neurogenic lineage, Cell, 62, 1035, 10.1016/0092-8674(90)90379-S

Hoehner, 1996, A developmental model of neuroblastoma: differentiating stroma-poor tumors’ progress along an extra-adrenal chromaffin lineage, Lab Invest, 75, 659

Gestblom, 1997, In vivo spontaneous neuronal to neuroendocrine lineage conversion in a subset of neuroblastomas, Am J Pathol, 150, 107

Påhlman, 1981, Phenotypic changes of human neuroblastoma cells in culture induced by 12-O-tetradecanoyl-phorbol-13-acetate, Int J Cancer, 28, 583, 10.1002/ijc.2910280509

Reynolds, 2003, Retinoid therapy of high-risk neuroblastoma, Cancer Lett, 197, 185, 10.1016/S0304-3835(03)00108-3

Rastinejad, 2001, Retinoid X receptor and its partners in the nuclear receptor family, Curr Opin Struct Biol, 11, 33, 10.1016/S0959-440X(00)00165-2

Sidell, 1982, Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro, J Natl Cancer Inst, 68, 589

Påhlman, 1984, Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation, Cell Differ, 14, 135, 10.1016/0045-6039(84)90038-1

Thiele, 1985, Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma, Nature, 313, 404, 10.1038/313404a0

Thiele, 1988, The expression of multiple proto-oncogenes is differentially regulated during retinoic acid induced maturation of human neuroblastoma cell lines, Oncogene, 3, 281

Hill, 1997, Characterization of the cholinergic neuronal differentiation of the human neuroblastoma cell line LA-N-5 after treatment with retinoic acid, Brain Res Dev Brain Res, 102, 53, 10.1016/S0165-3806(97)00076-X

Handler, 2000, Functional implications of the noradrenergic–cholinergic switch induced by retinoic acid in NB69 neuroblastoma cells, J Neurosci Res, 60, 311, 10.1002/(SICI)1097-4547(20000501)60:3<311::AID-JNR5>3.0.CO;2-X

Edsjö, 2003, Expression of trkB in human neuroblastoma in relation to MYCN expression and retinoic acid treatment, Lab Invest, 83, 813, 10.1097/01.LAB.0000074895.48776.D8

Huang, 1988, Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia, Blood, 72, 567, 10.1182/blood.V72.2.567.567

Påhlman, 1991, Insulin-like growth factor I shifts from promoting cell division to potentiating maturation during neuronal differentiation, Proc Natl Acad Sci USA, 88, 9994, 10.1073/pnas.88.22.9994

Åkerman, 1984, Functional differentiation of human ganglion cell derived neuroblastoma cell line SHSY-5Y induced by a phorbolester (TPA), Neurochem Int, 6, 77, 10.1016/0197-0186(84)90029-9

Parrow, 1992, Protein kinase C remains functionally active during TPA induced neuronal differentiation of SH-SY5Y human neuroblastoma cells, J Cell Physiol, 152, 536, 10.1002/jcp.1041520313

Zeidman, 1999, PKCepsilon, via its regulatory domain and independently of its catalytic domain, induces neurite-like processes in neuroblastoma cells, J Cell Biol, 145, 713, 10.1083/jcb.145.4.713

Anderson, 1997, Cellular and molecular biology of neural crest cell lineage determination, Trends Genet, 13, 276, 10.1016/S0168-9525(97)01187-6

Lavenius, 1994, Basic FGF and IGF-I promote differentiation of human SH-SY5Y neuroblastoma cells in culture, Growth Factors, 10, 29, 10.3109/08977199409019601

Airaksinen, 2002, The GDNF family: signaling, biological functions and therapeutic value, Nat Rev Neurosci, 3, 383, 10.1038/nrn812

Hishiki, 1998, Glial cell line-derived neurotrophic factor/neurturin-induced differentiation and its enhancement by retinoic acid in primary human neuroblastomas expressing c-Ret, GFR alpha-1, and GFR alpha-2, Cancer Res, 58, 2158

Bibel, 2000, Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system, Genes Dev, 14, 2919, 10.1101/gad.841400

Barbacid, 1994, The Trk family of neurotrophin receptors, J Neurobiol, 25, 1386, 10.1002/neu.480251107

Chao, 2003, Neurotrophins and their receptors: a convergence point for many signaling pathways, Nat Rev Neurosci, 4, 299, 10.1038/nrn1078

Clary, 1994, An alternatively spliced form of the nerve growth factor receptor TrkA confers an enhanced response to neurotrophin 3, Proc Natl Acad Sci USA, 91, 11133, 10.1073/pnas.91.23.11133

Strohmaier, 1996, A splice variant of the neurotrophin receptor trkB with increased specificity for brain-derived neurotrophic factor, Embo J, 15, 3332, 10.1002/j.1460-2075.1996.tb00698.x

Lamballe, 1993, trkC encodes multiple neurotrophin-3 receptors with distinct biological properties and substrate specificities, Embo J, 12, 3083, 10.1002/j.1460-2075.1993.tb05977.x

Tacconelli, 2004, TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma, Cancer Cell, 6, 347, 10.1016/j.ccr.2004.09.011

Hapner, 1998, Neural differentiation promoted by truncated trkC receptors in collaboration with p75(NTR), Dev Biol, 201, 90, 10.1006/dbio.1998.8970

Biffo, 1995, Selective binding and internalisation by truncated receptors restrict the availability of BDNF during development, Development, 121, 2461, 10.1242/dev.121.8.2461

Hoehner, 1995, Association of neurotrophin receptor expression and differentiation in human neuroblastoma, Am J Pathol, 147, 102

Azar, 1990, Multiple defects of the nerve growth factor receptor in human neuroblastomas, Cell Growth Differ, 1, 421

Nakagawara, 1993, Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma, New Engl J Med, 328, 847, 10.1056/NEJM199303253281205

Ryden, 1996, Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favorable tumor stage and good prognosis, Br J Cancer, 74, 773, 10.1038/bjc.1996.435

Yamashiro, 1996, Expression of TrkC in favorable human neuroblastomas, Oncogene, 12, 37

Nakagawara, 1994, Expression and function of TRK-B and BDNF in human neuroblastomas, Mol Cell Biol, 14, 759, 10.1128/MCB.14.1.759

Nakagawara, 1992, Inverse relationship between trk expression and N-myc amplification in human neuroblastomas, Cancer Res, 52, 1364

Kogner, 1993, Coexpression of messenger RNA for TRK proto-oncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis, Cancer Res, 53, 2044

Kwiatkowski, 1998, Schwann cell-conditioned medium promotes neuroblastoma survival and differentiation, Cancer Res, 58, 4602

Lavenius, 1995, Transfection of TRK-A into human neuroblastoma cells restores their ability to differentiate in response to nerve growth factor, Cell Growth Differ, 6, 727

Edsjö, 2001, Differences in early and late responses between neurotrophin-stimulated trkA- and trkC-transfected SH-SY5Y neuroblastoma cells, Cell Growth Differ, 12, 39

Matsushima, 1993, Expression of trkA cDNA in neuroblastomas mediates differentiation in vitro and in vivo, Mol Cell Biol, 13, 7447, 10.1128/MCB.13.12.7447

Poluha, 1995, TrkA neurogenic receptor regulates differentiation of neuroblastoma cells, Oncogene, 10, 185

Kim, 1999, Up-regulation of insulin-like growth factor-II expression is a feature of TrkA but not TrkB activation in SH-SY5Y neuroblastoma cells, Am J Pathol, 155, 1661, 10.1016/S0002-9440(10)65481-8

Matsumoto, 1995, Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells, Cancer Res, 55, 1798

Schramm, 2005, Biological effects of TrkA and TrkB receptor signaling in neuroblastoma, Cancer Lett, 228, 143, 10.1016/j.canlet.2005.02.051

Semenza, 2001, Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology, Trends Mol Med, 7, 345, 10.1016/S1471-4914(01)02090-1

Höckel, 2001, Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects, J Natl Cancer Inst, 93, 266, 10.1093/jnci/93.4.266

Jögi, 2002, Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype, PNAS, 99, 7021, 10.1073/pnas.102660199

Ghafar, 2003, Acute hypoxia increases the aggressive characteristics and survival properties of prostate cancer cells, Prostate, 54, 58, 10.1002/pros.10162

Helczynska, 2003, Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ, Cancer Res, 63, 1441

Brown, 2002, Tumor microenvironment and the response to anticancer therapy, Cancer Biol Ther, 1, 453, 10.4161/cbt.1.5.157

Tian, 1998, The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development, Genes Dev, 12, 3320, 10.1101/gad.12.21.3320

Jögi, 2004, Human neuroblastoma cells exposed to hypoxia: induction of genes associated with growth, survival, and aggressive behavior, Exp Cell Res, 295, 469, 10.1016/j.yexcr.2004.01.013

Löfstedt, 2004, Induction of ID2 expression by hypoxia-inducible factor-1: a role in dedifferentiation of hypoxic neuroblastoma cells, J Biol Chem, 279, 39223, 10.1074/jbc.M402904200

Påhlman, 2004, Notch signaling in neuroblastoma, Semin Cancer Biol, 14, 365, 10.1016/j.semcancer.2004.04.016

Axelson, 2005, Hypoxia-induced dedifferentiation of tumor cells—a mechanism behind heterogeneity and aggressiveness of solid tumors, Semin Cell Dev Biol, 16, 554, 10.1016/j.semcdb.2005.03.007

Hedborg, 2003, Evidence for hypoxia-induced neuronal-to-chromaffin metaplasia in neuroblastoma, Faseb J, 17, 598, 10.1096/fj.02-0390com

Jögi, 2002, Modulation of basic helix–loop–helix transcription complex formation by Id proteins during neuronal differentiation, J Biol Chem, 277, 9118, 10.1074/jbc.M107713200

Holmquist, 2005, Phenotypic persistence after reoxygenation of hypoxic neuroblastoma cells, Int J Cancer, 116, 218, 10.1002/ijc.21024

Nilsson, 2005, HIF-2α expression in human fetal paraganglia and neuroblastoma: relation to sympathetic differentiation, glucose deficiency, and hypoxia, Exp Cell Res, 303, 447, 10.1016/j.yexcr.2004.10.003

Ceradini, 2004, Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1, Nat Med, 10, 858, 10.1038/nm1075

Yokota, 2001, Id and development, Oncogene, 20, 8290, 10.1038/sj.onc.1205090